Following the merger of Acceres (Promovert, GAB and Biotek Europe) with SynTech Research announced in 2020, a new company, ECT (ECT Oekotoxikologie GmbH) has now joined SynTech Research.
ECT’s thirty staff deliver aquatic and terrestrial ecotoxicology laboratory and field services centred at 1500 m² of laboratories/offices in Flörsheim am Main, Germany. As well as adding to SynTech’s overall GEP and GLP field trials capability in Germany, for both local and EU work, the ECT acquisition will add significantly to SynTech’s existing specialized ecotoxicology capabilities in France, Spain, US and Brazil.
“We are extremely pleased to add ECT, with is expert staff and facilities, to the growing SynTech Research enterprise. This and further acquisitions in the pipeline for 2022 are key in the expansion of SynTech’s Ecotoxicology and Regulatory services in Europe and globally,” says Dr Khosro Khodayari, CEO of SynTech Research.